file_download Download slide in HQ

Index for
slide deck

Title

Hypothetical model for the pathological–clinical continuum of Alzheimer’s disease
Hypothetical model for the pathological–clinical continuum of Alzheimer’s disease

!--?xml version="1.0" encoding="UTF-8" standalone="yes"?-- The slide represents a hypothetical model for the pathological-clinical continuum of AD.[Sperling et al., 2011] The ‘preclinical’ stage precedes mild cognitive impairment (MCI) and includes individuals who have ev…

file_download Download slide in HQ
What is Alzheimer’s disease?
What is Alzheimer’s disease?

!--?xml version="1.0" encoding="UTF-8" standalone="yes"?-- Alzheimer’s disease (AD) is the most common cause of dementia, accounting for approximately 60–80% of all dementia cases.[Alzheimer’s Association, 2016] AD is a degenerative and progressive disorder, associated wi…

file_download Download slide in HQ
Accumulation of Alzheimer’s disease risk factors over time
Accumulation of Alzheimer’s disease risk factors over time

!--?xml version="1.0" encoding="UTF-8" standalone="yes"?-- The risk factors and protective factors for the development of AD/dementia accumulate over a lifetime, as shown in this slide.[Jiang et al., 2013; Bendlin et al., 2010; Winblad et al., 2016] Many risk and protecti…

file_download Download slide in HQ
Examples of symptoms of Alzheimer’s disease
Examples of symptoms of Alzheimer’s disease

!--?xml version="1.0" encoding="UTF-8" standalone="yes"?-- In general, the symptoms of AD can be divided into three categories – cognitive, functional, and neuropsychiatric. Cognitive symptoms – the main areas of cognition that can be impaired over the course of AD includ…

file_download Download slide in HQ
Projected increase in the prevalence of Alzheimer’s disease
Projected increase in the prevalence of Alzheimer’s disease

!--?xml version="1.0" encoding="UTF-8" standalone="yes"?-- Worldwide, in 2015, an estimated 46.8 million people were living with dementia.[WHO, 2015] In the US, in 2016, an estimated 5.2 million people >65 years of age were affected by AD.[Hebert et al., 2013] Age is one …

file_download Download slide in HQ
Current approaches to AD management
Current approaches to AD management

!--?xml version="1.0" encoding="UTF-8" standalone="yes"?-- Full reference details: American Psychiatric Association; Rabins PV, Rovner BW, Rummans T, et al. Guideline watch for the practice guideline for the treatment of patients with Alzheimer’s disease and other dementi…

file_download Download slide in HQ
Psychosocial therapies for AD
Psychosocial therapies for AD

!--?xml version="1.0" encoding="UTF-8" standalone="yes"?-- Full reference details: American Psychiatric Association; Rabins PV, Rovner BW, Rummans T, et al. Guideline watch for the practice guideline for the treatment of patients with Alzheimer’s disease and other dementi…

file_download Download slide in HQ

Related content

grid_view Slide Deck
Major depressive disorder (MDD) – Definitions and Diagnosis

This slide deck offers a comprehensive overview of Major Depressive Disorder (MDD), including its definitions, diagnostic criteria, symptom profiles, clinical course, differential diagnoses, and validated rating tools based on DSM-5-TR and ICD-11 guidelines.

02.07.2025 Depression
image Image Graphic showing extracellular, multimerization, and intracellular targets of alpha-synuclein for therapeutic intervention in Parkinson’s disease
Possible α-synuclein targets for development of therapies for Parkinson’s disease

Overview of three therapeutic strategies targeting alpha-synuclein in the development of disease-modifying treatments for Parkinson’s disease

26.06.2025 Parkinson’s Disease
image Image Chart showing progression of functional decline in Parkinson’s disease with different treatment approaches, from symptomatic benefit to disease modification.
Disease modification in Parkinson’s disease

Graphical representation of how various treatment strategies can impact disease progression in Parkinson’s disease, from symptom relief to potential cure

26.06.2025 Parkinson’s Disease